Neuralstem wins patent for neurogenesis - Washington Business Journal:

paramonaxogilozi.blogspot.com
Rockville-based Neuralstem (AMEX: CUR) announcedx Thursday that it had been granted a patent on four new chemicalo entities that boost the generation of new The company’s patent application, titled “Use of Fused Nicotinamides to Promote Neurogenesis,” claimz four chemical entities and any pharmaceutical composition includiny them. “The ability to promote neurogenesis — the birth of new neuronz in the adultbrain — has recentlyh been a focus of intensd research by scientists and pharmaceutical companies worldwide, said Neuralstemk CEO Richard Garr.
“These four compounds, with potent demonstratecd neurogenic activity were discoveredentirely in-house and are owned by the These are the only drugz we are aware of with the demonstrate ability to stimulate neurogenesis of normal adult brain cells." Neuralstenm expects to be in a Phase I safety trials for treatmeng of major depression with the lead compounr from the four-chemical group by early next year. The company also expectsw to be testing compoundsfor stroke, traumatic brain injury and other major indications.